Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
8395 | 1188 | 39.1 | 86% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
724 | 12071 | HEART FAILURE//NATRIURETIC PEPTIDES//B TYPE NATRIURETIC PEPTIDE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | HEART FAILURE WITH PRESERVED EJECTION FRACTION | Author keyword | 89 | 62% | 8% | 92 |
2 | DIASTOLIC HEART FAILURE | Author keyword | 46 | 38% | 8% | 95 |
3 | PRESERVED EJECTION FRACTION | Author keyword | 44 | 56% | 5% | 54 |
4 | HFPEF | Author keyword | 9 | 47% | 1% | 14 |
5 | HEART FAILURE WITH PRESERVED LEFT VENTRICULAR EJECTION FRACTION | Author keyword | 6 | 80% | 0% | 4 |
6 | PRESERVED LEFT VENTRICULAR FUNCTION | Author keyword | 6 | 71% | 0% | 5 |
7 | PRESERVED SYSTOLIC FUNCTION | Author keyword | 5 | 47% | 1% | 8 |
8 | EVIDENCE BASED CARDIOVASC MED | Address | 5 | 38% | 1% | 10 |
9 | HFNEF | Author keyword | 4 | 56% | 0% | 5 |
10 | DIASTOLIC | Author keyword | 4 | 18% | 2% | 20 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SYSTOLIC FUNCTION | 30 | 12% | 20% | 235 |
2 | I PRESERVE | 30 | 100% | 1% | 12 |
3 | PRESERVED EJECTION FRACTION | 29 | 16% | 14% | 161 |
4 | ACTIVE RELAXATION | 18 | 83% | 1% | 10 |
5 | VENTRICULAR SYSTOLIC FUNCTION | 17 | 16% | 8% | 100 |
6 | NORMAL EJECTION FRACTION | 16 | 27% | 4% | 50 |
7 | PRESERVED SYSTOLIC FUNCTION | 12 | 29% | 3% | 35 |
8 | DIG TRIAL | 8 | 34% | 2% | 20 |
9 | SCORE METHODS | 6 | 44% | 1% | 11 |
10 | MEDIATED ARTERIAL DILATION | 6 | 71% | 0% | 5 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
A Novel Paradigm for Heart Failure With Preserved Ejection Fraction Comorbidities Drive Myocardial Dysfunction and Remodeling Through Coronary Microvascular Endothelial Inflammation | 2013 | 151 | 92 | 38% |
How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology | 2007 | 907 | 145 | 28% |
Epidemiology and clinical course of heart failure with preserved ejection fraction | 2011 | 113 | 69 | 67% |
Heart failure with preserved ejection fraction: a clinical dilemma | 2014 | 20 | 102 | 68% |
Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment | 2011 | 160 | 122 | 39% |
Heart Failure With Preserved Ejection Fraction Mechanisms, Clinical Features, and Therapies | 2014 | 23 | 149 | 51% |
Heart failure with preserved ejection fraction: Refocusing on diastole | 2015 | 3 | 91 | 54% |
How do patients with heart failure with preserved ejection fraction die? | 2013 | 24 | 50 | 70% |
Pre-Clinical Diastolic Dysfunction | 2014 | 15 | 71 | 49% |
What Have We Learned About Patients With Heart Failure and Preserved Ejection Fraction From DIG-PEF, CHARM-Preserved, and I-PRESERVE? | 2012 | 33 | 45 | 62% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | EVIDENCE BASED CARDIOVASC MED | 5 | 38% | 0.8% | 10 |
2 | GERIATR HEART FAILURE CLIN | 2 | 36% | 0.4% | 5 |
3 | CARDIOL UHLCTY COUNCIL OSTERGOTLAND | 2 | 67% | 0.2% | 2 |
4 | RHJ | 2 | 33% | 0.4% | 5 |
5 | CARDIOVASC MED ENDOCRINOL METAB | 2 | 43% | 0.3% | 3 |
6 | CIC IT U 804 | 2 | 43% | 0.3% | 3 |
7 | SH HO CARDIOVASC DIS STROKE | 2 | 43% | 0.3% | 3 |
8 | LORRAINE HEART BLOOD VESSELS | 1 | 100% | 0.2% | 2 |
9 | INSERM 1099 | 1 | 40% | 0.2% | 2 |
10 | INTERNAL MED THER EUT A8 | 1 | 12% | 0.6% | 7 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000194323 | CARDIOVASC BIOPHYS//DIASTOLIC FUNCTION//DIASTOLE |
2 | 0.0000188792 | EUROPEAN JOURNAL OF HEART FAILURE//JOURNAL OF CARDIOVASCULAR NURSING//JOURNAL OF CARDIAC FAILURE |
3 | 0.0000157101 | ANTIDIABETIC PHARMACOTHERAPY//CHAIR GERIATR SURG//HEART FAILURE INCOR |
4 | 0.0000127303 | NESIRITIDE//ACUTE HEART FAILURE//CARDIORENAL SYNDROME |
5 | 0.0000100801 | LEFT ATRIAL VOLUME//LEFT ATRIAL FUNCTION//LEFT ATRIUM |
6 | 0.0000084762 | LEFT VENTRICULAR HYPERTROPHY//LEFT VENTRICULAR MASS//LEFT VENTRICULAR GEOMETRY |
7 | 0.0000084087 | SPECKLE TRACKING//SPECKLE TRACKING ECHOCARDIOGRAPHY//JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY |
8 | 0.0000077293 | CARDIORENAL ANEMIA SYNDROME//CONGEST HEART FAILURE UNIT//PL CARDIOVASC SYST |
9 | 0.0000076390 | B TYPE NATRIURETIC PEPTIDE//NT PROBNP//NATRIURETIC PEPTIDES |
10 | 0.0000069166 | OBESITY CARDIOMYOPATHY//CARDIAC REHABIL CARDIOVASC DIS//OXFORD CLIN CARDIOVASC IL |